Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Victorian Clinical Genetics Services, |
RCV004788554 | SCV005398850 | uncertain significance | Polycystic kidney disease, adult type | 2024-10-11 | criteria provided, single submitter | clinical testing | Based on the classification scheme VCGS_Germline_v1.3.5, this variant is classified as VUS-3A. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with polycystic kidney disease 1 (MIM#173900). (I) 0107 - This gene is associated with autosomal dominant disease. Polycystic kidney disease 1 (MIM#173900) is predominantly caused by monoallelic variants, with rare reports of biallelic variants causing disease (OMIM). (I) 0200 - Variant is predicted to result in a missense amino acid change from leucine to proline. (I) 0251 - This variant is heterozygous. (I) 0302 - Variant is present in gnomAD (v4) <0.001 for a dominant condition (1 heterozygote, 0 homozygotes). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v4: 4 heterozygotes, 0 homozygotes). (I) 0502 - Missense variant with conflicting in silico predictions and high conservation. (I) 0600 - Variant is located in the annotated PKD domain (DECIPHER). (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0803 - This variant has limited previous evidence of pathogenicity in unrelated individuals. This variant has been observed in two unrelated individuals with ADPKD (PMIDs: 31079206, 27499327). (SP) 0906 - Segregation evidence for this variant is inconclusive. This variant was observed in a compound heterozygous child with early onset PKD. This variant was paternally inherited and the father showed signs of PKD, while the mother appeared asymptomatic. Their asymptomatic daughter was heterozygous for the maternal allele (PMID: 31079206). (I) 1010 - Functional evidence for this variant is inconclusive. Relative expression levels of PC1 and TRPP2 proteins, and intracellular calcium levels due to ATP and PAF evoked channel activation pathways have been measured in an ADPKD affected individual with this variant. However, these values were not used in determining the impact this mutation had on the pathogenesis of PKD in this paper (PMID: 31514750). (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign |